- September 13, 2023
Wilkinson, Rhee Awarded NIH Research Project Grants
- August 03, 2023Source: CNN
Nothing worked for her teenage son's depression, until his doctor suggested ketamine
- July 06, 2023Source: JAMA Psychiatry
The Intricate Interaction Between Expectations and Therapeutic Outcomes of Psychedelic Agents
- June 21, 2023Source: Neuropsychopharmacology
Long term Structural and Functional Neural Changes Following a Single Infusion of Ketamine in PTSD
- April 10, 2023
Ketamine: Handle With Care
- February 21, 2023Source: Trembling EMT Podcast
Sanacora, Holmes Discuss Ketamine's Impact on Depression on Podcast
Yale Depression Research Program
Operated jointly by the Yale University School of Medicine Department of Psychiatry and Connecticut Mental Health Center, the Yale Depression Research Program has, for over 30 years, been committed to advancing the treatment of depression. By engaging in studies that seek to elucidate the underlying neurobiology of depression, we are striving to improve our ability to diagnose and treat mood disorders.
Depression remains one of the most common and debilitating medical problems throughout the world. At the Yale Depression Research Program, we are committed to advancing our ability to understand, diagnose, and treat depression through innovative research.